Patent 7244861 was granted and assigned to Eisai (company) on July, 2007 by the United States Patent and Trademark Office.
The present invention provides a medicament comprising a benzene compound useful as an insulin sensitizer, a salt thereof or a hydrate of them and a derivative of them as the active ingredient. Specifically, it provides a benzene compound represented by the following formula, a salt thereof or a hydrate of them.